These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 29273972)
1. The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011-2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group. Yamasaki D; Tanabe M; Muraki Y; Kato G; Ohmagari N; Yagi T Infection; 2018 Apr; 46(2):207-214. PubMed ID: 29273972 [TBL] [Abstract][Full Text] [Related]
2. Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance. Koizumi R; Kusama Y; Muraki Y; Ishikane M; Yamasaki D; Tanabe M; Ohmagari N PLoS One; 2021; 16(3):e0248338. PubMed ID: 33735299 [TBL] [Abstract][Full Text] [Related]
3. The first national survey of antimicrobial use among dentists in Japan from 2015 to 2017 based on the national database of health insurance claims and specific health checkups of Japan. Ono A; Ishikane M; Kusama Y; Tanaka C; Ono S; Tsuzuki S; Muraki Y; Yamasaki D; Tanabe M; Ohmagari N PLoS One; 2020; 15(12):e0244521. PubMed ID: 33370390 [TBL] [Abstract][Full Text] [Related]
4. The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. Inose R; Muraki Y; Kamimoto Y; Kusama Y; Koizumi R; Yamasaki D; Ishikane M; Tanabe M; Ohmagari N J Infect Chemother; 2022 Feb; 28(2):356-358. PubMed ID: 34916136 [TBL] [Abstract][Full Text] [Related]
5. Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012-2015. Hashimoto H; Saito M; Sato J; Goda K; Mitsutake N; Kitsuregawa M; Nagai R; Hatakeyama S Int J Infect Dis; 2020 Feb; 91():1-8. PubMed ID: 31730926 [TBL] [Abstract][Full Text] [Related]
6. The Use of Topical Antibiotics Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data in 2017. Nakanishi T; Inose R; Kusama Y; Ishikane M; Kajihara T; Yahara K; Sugai M; Ohge H; Ohmagari N; Muraki Y Jpn J Infect Dis; 2022 Mar; 75(2):177-182. PubMed ID: 34588368 [TBL] [Abstract][Full Text] [Related]
7. An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. Mita Y; Inose R; Goto R; Kusama Y; Koizumi R; Yamasaki D; Ishikane M; Tanabe M; Ohmagari N; Muraki Y J Infect Chemother; 2021 Jul; 27(7):972-976. PubMed ID: 33618976 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and limitations of national antimicrobial surveillance according to sales and claims data. Kusama Y; Muraki Y; Tanaka C; Koizumi R; Ishikane M; Yamasaki D; Tanabe M; Ohmagari N PLoS One; 2021; 16(5):e0251299. PubMed ID: 33974635 [TBL] [Abstract][Full Text] [Related]
9. Regional Variation of Antimicrobial Use in Japan from 2013-2016, as Estimated by the Sales Data. Kusama Y; Ishikane M; Tanaka C; Kimura Y; Yumura E; Hayakawa K; Muraki Y; Yamasaki D; Tanabe M; Ohmagari N Jpn J Infect Dis; 2019 Sep; 72(5):326-329. PubMed ID: 31061356 [TBL] [Abstract][Full Text] [Related]
10. Nationwide study of outpatient oral antimicrobial utilization patterns for children in Japan (2013-2016). Kinoshita N; Morisaki N; Uda K; Kasai M; Horikoshi Y; Miyairi I J Infect Chemother; 2019 Jan; 25(1):22-27. PubMed ID: 30396820 [TBL] [Abstract][Full Text] [Related]
11. Effects of population age structure on parenteral antimicrobial use estimations. Koizumi R; Kusama Y; Asai Y; Tsuzuki S; Aoyagi K; Ishikane M; Muraki Y; Ohmagari N Sci Rep; 2023 Jan; 13(1):840. PubMed ID: 36646845 [TBL] [Abstract][Full Text] [Related]
12. The effects of Japan's National Action Plan on Antimicrobial Resistance on antimicrobial use. Kusama Y; Tsuzuki S; Muraki Y; Koizumi R; Ishikane M; Ohmagari N Int J Infect Dis; 2021 Feb; 103():154-156. PubMed ID: 33227519 [TBL] [Abstract][Full Text] [Related]
13. The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study. Morioka H; Hirabayashi A; Iguchi M; Tomita Y; Kato D; Sato N; Hyodo M; Kawamura N; Sadomoto T; Ichikawa K; Inagaki T; Kato Y; Kouyama Y; Ito Y; Yagi T Am J Infect Control; 2016 Jul; 44(7):e119-23. PubMed ID: 27372390 [TBL] [Abstract][Full Text] [Related]
14. Prescription of antimicrobial agents to elderly people in relation to the type of infection. Leistevuo T; Isoaho R; Klaukka T; Kivelä SL; Huovinen P Age Ageing; 1997 Sep; 26(5):345-51. PubMed ID: 9351478 [TBL] [Abstract][Full Text] [Related]
15. Search for Indexes to Evaluate Trends in Antibiotic Use in the Sub-Prefectural Regions Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Mizuno K; Inose R; Matsui Y; Takata M; Yamasaki D; Kusama Y; Koizumi R; Ishikane M; Tanabe M; Ohge H; Ohmagari N; Muraki Y Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740169 [TBL] [Abstract][Full Text] [Related]
16. Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. Tsutsui A; Yahara K; Shibayama K J Infect Chemother; 2018 Jun; 24(6):414-421. PubMed ID: 29428566 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic consumption in Belgian acute care hospitals: analysis of the surveillance methodology, consumption evolution 2003 to 2016 and future perspectives. Vandael E; Magerman K; Coenen S; Goossens H; Catry B Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771707 [TBL] [Abstract][Full Text] [Related]
18. Japanese antimicrobial consumption surveillance: First report on oral and parenteral antimicrobial consumption in Japan (2009-2013). Muraki Y; Yagi T; Tsuji Y; Nishimura N; Tanabe M; Niwa T; Watanabe T; Fujimoto S; Takayama K; Murakami N; Okuda M J Glob Antimicrob Resist; 2016 Dec; 7():19-23. PubMed ID: 27973324 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018. Hosaka Y; Muraki Y; Kajihara T; Kawakami S; Hirabayashi A; Shimojima M; Ohge H; Sugai M; Yahara K J Antimicrob Chemother; 2024 Feb; 79(2):312-319. PubMed ID: 38084874 [TBL] [Abstract][Full Text] [Related]
20. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Di Pentima MC; Chan S Pediatr Infect Dis J; 2010 Aug; 29(8):707-11. PubMed ID: 20182398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]